Ferrosan Medical Devices A/S
Ferrosan Medical Devices is known for developing and producing medico products in bleeding medicine technology and biopsy devices for cancer diagnostics.
Since 1947, FeMD has developed and manufactured surgical haemostatic devices for use by healthcare professionals. In this context, FeMD has a global partnership agreement with US-based Johnson & Johnson MedTech, which is responsible for sales and marketing of FeMD鈥檚 haemostatic devices in more than 100 countries. In addition, FeMD develops and produces handheld biopsy devices, used in the diagnosis of breast cancer. These are developed and distributed in collaboration with a global partner.
The Danish medical device company has more than 430 employees and production facilities in S酶borg in Denmark and Szczecin in Poland. In 2024, FeMD had revenues totalling around DKK 1 billion. In 2010, FeMD was established as an independent legal entity. Prior to that, FeMD had been part of the Ferrosan A/S group, which until 1995 was owned by Novo Nordisk A/S.
The Lundbeck Foundation owns 30% of FeMD in an ownership consortium with Kirk Kapital and ATP.
